Insights - Page 2 of 5 - Health System Readiness

Opinion

Glossary: what does readiness really mean?

The terms readiness, preparedness, resilience, strengthening and sustainability often appear in similar health contexts, but they mean different things.

News

Introducing the UK Molecular Radiotherapy Consortium

The UK Molecular Radiotherapy Consortium is an alliance of clinicians and patient advocates formed to support equitable access to evidence-based theranostic MRT across the UK.

News

New masterclass video to support application of the Readiness Assessment Framework

HPP has developed a masterclass video which explains how to apply the Readiness Assessment Framework.

Opinion

Why we need to think about readiness for ALS

ALS has a profound impact on people’s lives; new innovations are on the horizon, but it is important to consider how ready our health systems are to integrate new therapies.

Opinion

Why we need readiness in NASH

Health systems need to be ready to respond to evolving evidence to ensure they can always deliver efficient and equitable care. The approval of a therapy would transform care for n

News

HPP launches framework to assess health system readiness

HPP is pleased to launch the Readiness Assessment Framework, which can be used to assess health system readiness for a number of different components of care.

Opinion

When is the right time to think about health system readiness?

Decision-makers must plan for the sustainable and timely integration of new technologies and processes into care.

Opinion

How consistent terminology can aid integration of radioligand therapy

Inconsistent use of terminology presents challenges to building awareness of radioligand therapy and appropriately integrating it into care.

Opinion

The impact of COVID-19 highlights the need for innovative therapies in cancer care

COVID-19 has caused widespread disruption to cancer care. New approaches could provide more options for people with advanced, complex or metastatic cancers.

News

Call to share experiences of integrating radioligand therapy into care

The Health Policy Partnership wants to better understand what actions and initiatives have taken place to improve the delivery of radioligand therapy.

Opinion

World Theranostics Day 2022: what are theranostics and how can we use them?

On World Theranostics Day 2022, HPP explores the ongoing innovation and advancement in the field of theranostics.

Opinion

We need continued research to ensure wider access to innovative therapies as soon as they are approved

In this guest blog, Dr Erik Briers emphasises the need for continued research and planning to make radioligand therapy a more viable treatment option.